Clinical Trials Contact

About this Clinical Trial

Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Your Message Will Go To

Patrick Yuan

650-721-4077


All fields are required. *

Preferred contact method*

To:

Patrick Yuan

650-721-4077



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine